Form 4: Tenet Healthcare Director Sells Over 3,000 Shares of Common Stock

Richard W. Fisher, a Director at Tenet Healthcare Corp., reported the sale of 3,077 shares of common stock at a price of $165.72 per share on May 27, 2025.

Summary

• Richard W. Fisher, a Director of Tenet Healthcare Corp. (THC), reported a transaction involving the company's common stock.
• On May 27, 2025, Mr. Fisher disposed of 3,077 shares of common stock.
• The shares were sold at a price of $165.72 per share.
• Following this transaction, Mr. Fisher beneficially owns 12,128 shares of Tenet Healthcare Corp. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, which can sometimes be perceived as a lack of confidence, although the transaction was pre-arranged under a 10b5-1 plan. This type of filing typically does not contain positive news about company operations.

Negatives

• The sale of shares by a director, even if pre-arranged, can sometimes be perceived negatively by investors as it might suggest a lack of confidence, although this is not explicitly stated in the filing.

Risks

• Potential negative investor sentiment or perception due to insider selling, which could put downward pressure on the stock price.

Future Outlook

This Form 4 filing reports a past transaction and does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is specific to an insider transaction at Tenet Healthcare Corp. and does not provide broader insights into industry trends or competitive landscape within the healthcare sector. It reflects an individual director's portfolio management decision.

Related Party Transactions

• The reported transaction is a direct sale of common stock by Richard W. Fisher, a Director of Tenet Healthcare Corp., which constitutes a related party transaction under SEC regulations.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal, potentially influencing their investment decisions or sentiment towards the stock.

Key Dates

Recommendation

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Stock Sale, Director, Richard W. Fisher, Healthcare, Beneficial Ownership